- Home
- IRON vs PBI Comparison
IRON vs PBI Comparison
Compare IRON & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- PBI
- Stock Information
- Founded
- IRON 2017
- PBI 1920
- Country
- IRON United States
- PBI United States
- Employees
- IRON N/A
- PBI N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- PBI Office Equipment/Supplies/Services
- Sector
- IRON Health Care
- PBI Miscellaneous
- Exchange
- IRON Nasdaq
- PBI Nasdaq
- Market Cap
- IRON 2.0B
- PBI 2.0B
- IPO Year
- IRON N/A
- PBI N/A
- Fundamental
- Price
- IRON $60.35
- PBI $11.84
- Analyst Decision
- IRON Strong Buy
- PBI
- Analyst Count
- IRON 11
- PBI 0
- Target Price
- IRON $95.73
- PBI N/A
- AVG Volume (30 Days)
- IRON 325.5K
- PBI 4.1M
- Earning Date
- IRON 08-07-2025
- PBI 07-30-2025
- Dividend Yield
- IRON N/A
- PBI 2.71%
- EPS Growth
- IRON N/A
- PBI N/A
- EPS
- IRON N/A
- PBI N/A
- Revenue
- IRON N/A
- PBI $1,970,913,000.00
- Revenue This Year
- IRON N/A
- PBI N/A
- Revenue Next Year
- IRON N/A
- PBI $0.40
- P/E Ratio
- IRON N/A
- PBI N/A
- Revenue Growth
- IRON N/A
- PBI N/A
- 52 Week Low
- IRON $30.82
- PBI $6.22
- 52 Week High
- IRON $68.73
- PBI $13.11
- Technical
- Relative Strength Index (RSI)
- IRON 57.22
- PBI 57.68
- Support Level
- IRON $57.54
- PBI $11.11
- Resistance Level
- IRON $64.83
- PBI $11.71
- Average True Range (ATR)
- IRON 2.14
- PBI 0.39
- MACD
- IRON -0.19
- PBI 0.01
- Stochastic Oscillator
- IRON 46.60
- PBI 91.09
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About PBI Pitney Bowes Inc.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.